Format

Send to

Choose Destination
See comment in PubMed Commons below
J Affect Disord. 1987 Jul-Aug;13(1):45-50.

Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.

Author information

1
MRC Unit of Clinical Pharmacology, Littlemore Hospital, Oxford, U.K.

Abstract

5-Hydroxytryptamine (5-HT) receptor binding was determined in intact human platelets using 125I-iodolysergic acid diethylamide (125I-iodoLSD). The assay revealed that platelets possess a single population of specific binding sites for 125I-iodoLSD which have a high affinity for the 5-HT2 receptor antagonists, ketanserin and spiperone. There was no difference in platelet 125I-iodoLSD receptor binding between depressed patients and controls. However, treatment with tricyclic antidepressants increased the number of 125I-iodoLSD receptor binding sites without significantly altering their affinity.

PMID:
2959699
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center